INVIDON-35 XR Tablets

Total Freedom from heart pain


Composition: Trimetazidine HCI B.P. 35 mg (Modified Release)

  • Possesses a direct anti-ischemic effect on myocardium & stimulates the coronary blood flow.
  • Significantly improves myocardial glucose utilization through inhibition of fatty acid oxidation.
  • Well-tolerated and safe drug for patients with diabetic myocardiopathy.
  • Profound cytoprotective action during ischemia.


  • Angina pectoris

Trimetazidine HCl

  • Class of medications: Partial fatty acid oxidation inhibitors (so-called PFox inhibitors)
  • Trimetazidine hydrochloride is an aromatic amine.
  • Efficient cytoprotective anti-anginal drug that exerts anti-ischemic activity.¹
  • Safely increases exercise capacity, and decreases the anginal incidence and left-ventricular (LV) dysfunction.²
  • Provides long-term cardioprotection by hydroionic balancing and coronary microcirculation.3 
  • Shows 63% reduction in angina crisis as compared to isosorbide mononitrate.4


  1. Indian J Pharm Sci. 2010 Nov-Dec; 72(6): 704-709
  2. Expert Opin Premacother 2001 May;2(5):857-75
  3. 2005 Feb; 91(2): 161-165
  4. Ann Cardiol Angeiol (Paris). 2002 Nov;51(5):268-74